Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGD | P52209 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12518968 | 1.00 | PGD (0.42) | PGDALDH1A1MAPTITGA4MAPK1 | |
| SCHEMBL11218855 | 0.85 | PGD (0.42) | PGDALDH1A1MAPTITGA4MAPK1 | |
| SCHEMBL14750611 | 0.85 | PGD (0.42) | PGDALDH1A1MAPTITGA4MAPK1 | |
| SCHEMBL13122486 | 0.85 | PGD (0.42) | PGDALDH1A1MAPTITGA4MAPK1 | |
| SCHEMBL16421028 | 0.84 | TSHR (0.39) | PGDALDH1A1MAPK1NPSR1KMT2A | |
| SCHEMBL16421031 | 0.84 | TSHR (0.39) | PGDALDH1A1MAPK1NPSR1KMT2A | |
| SCHEMBL16488727 | 0.84 | TSHR (0.39) | PGDALDH1A1MAPK1NPSR1KMT2A | |
| SCHEMBL12826506 | 0.82 | ALDH1A1 (0.47) | PGDALDH1A1MAPTITGA4MAPK1 | |
| SCHEMBL9979878 | 0.82 | ALDH1A1 (0.47) | PGDALDH1A1MAPTITGA4MAPK1 | |
| SCHEMBL675867 | 0.82 | ALDH1A1 (0.47) | PGDALDH1A1MAPTITGA4MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8361991-B2 | Hydroxylated amide skin moisturizer | L'OREAL (FR) | 2013-01-29 | — | — | US | disclosed |
| WO-2011087995-A2 | ORGANIC COMPOUNDS | BARRY CLIFTON (US) | 2011-07-21 | — | — | WO | disclosed |
| US-20100009933-A1 | HYDROXYLATED AMIDE SKIN MOISTURIZER | L'OREAL (FR) | 2010-01-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100009933-A1 | HYDROXYLATED AMIDE SKIN MOISTURIZER | H1-0, H1-3, H1-4 | PGD 1154/4885ALDH1A1 248/4885MAPT 4065/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.